Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
CC transcript
|
|
AUXILIUM PHARMACEUTICALS INC (AUXL)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/16/2016 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 03/05/2015 |
SC TO-I/A
| Form SC TO-I/A - Tender offer statement by Issuer: [Amend] |
| 02/17/2015 |
SC 13G/A
| Palo Alto Investors, LLC reports a 9.6% stake in Auxilium Pharmaceuticals, Inc. |
| 02/17/2015 |
SC 13G
| AQR CAPITAL MANAGEMENT LLC reports a 5.1% stake in Auxilium Pharmaceuticals, Inc. |
| 02/17/2015 |
SC 13G/A
| PUTNAM INVESTMENTS LLC reports a 1.2% stake in AUXILIUM PHARMACEUTICALS INC |
| 02/12/2015 |
SC 13G/A
| Artal International S.C.A. reports a 3.2% stake in AUXILIUM PHARMACEUTICALS, INC. |
| 02/10/2015 |
SC 13G
| Pentwater Capital Management LP reports a 7.4% stake in Auxilium Pharmaceuticals Inc. |
| 02/10/2015 |
SC 13G/A
| VANGUARD GROUP INC reports a 6.1% stake in Auxilium Pharmaceuticals Inc |
| 02/04/2015 |
SC 13G/A
| Flynn James E reports a 0% stake in Auxilium Pharmaceuticals, Inc. |
| 02/04/2015 |
SC TO-I/A
| Form SC TO-I/A - Tender offer statement by Issuer: [Amend] |
| 02/03/2015 |
SC TO-I
| Form SC TO-I - Tender offer statement by Issuer: |
| 02/02/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/30/2015 |
8-K/A
| Quarterly results |
| 01/30/2015 |
SC 13G/A
| BlackRock Inc. reports a 6.4% stake in AUXILIUM PHARMACEUTICALS INC |
| 01/30/2015 |
4
| WILLS ALAN (EVP, Corporate Development) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC |
| 01/30/2015 |
4
| Tursi James Patrick (Chief Medical Officer) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC |
| 01/30/2015 |
4
| Saik Andrew (CFO) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC|
Txns:
| Disposed of 10,000 shares
@ $36.53, valued at
$365.3k
Disposed of 165,000 options to buy
@ $17.51, valued at
$2.9M
|
|
| 01/30/2015 |
4
| KOVEN ANDREW I (EVP, CAO, GC and Secretary) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC |
| 01/30/2015 |
4
| JOBES ELIZABETH VARKI (Chief Compliance Officer) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC |
| 01/30/2015 |
4
| Glickman Mark A (EVP - Sales and Marketing) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC |
| 01/30/2015 |
4
| Armstrong Jennifer Lou (Senior Vice President, HR) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC |
| 01/30/2015 |
4
| ADAMS ADRIAN (CEO and President) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC |
| 01/30/2015 |
4
| MCKEE WILLIAM (Director) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC |
| 01/30/2015 |
4
| Lurker Nancy (Director) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC |
| 01/30/2015 |
4
| FRIEDMAN PAUL A (Director) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC|
Txns:
| Disposed of 5,361 shares
@ $0
Disposed of 5,000 shares
@ $36.53, valued at
$182.7k
Disposed of 15,000 options to buy
@ $29.72, valued at
$445.8k
Disposed of 5,000 options to buy
@ $24.62, valued at
$123.1k
Disposed of 5,000 options to buy
@ $20.44, valued at
$102.2k
|
|
| 01/30/2015 |
4
| FETZER OLIVER (Director) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC |
| 01/30/2015 |
4
| CLASSON ROLF A (Director) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC|
Txns:
| Disposed of 260 shares
@ $0
Disposed of 10,000 shares
@ $36.53, valued at
$365.3k
Disposed of 50,000 options to buy
@ $35.19, valued at
$1.8M
Disposed of 5,000 options to buy
@ $20.44, valued at
$102.2k
|
|
| 01/30/2015 |
4
| Brandt Peter C. (Director) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC |
| 01/29/2015 |
8-K
| Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disp... |
| 01/27/2015 |
8-K
| Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits|
Docs:
|
"AUXILIUM ANNOUNCES RESULTS FROM SPECIAL MEETING OF STOCKHOLDERS Chesterbrook, PA, January 27, 2015 — Auxilium Pharmaceuticals, Inc. , a specialty biopharmaceutical company, announced that it held a special meeting of its stockholders today at 8:30 a.m. ET to approve matters relating to the previously announced proposed merger with Endo International plc. The proposal to adopt the amended and restated agreement and plan of merger was passed by stockholders with approximately 84 percent of outstanding shares voting in favor. Auxilium anticipates that the proposed merger transaction will close on Thursday, January 29, 2015. “As we near the anticipated close of the transaction, I would like to take a moment to thank the Auxilium Board of Directors, the Executive Leadership Team and all of the ..." |
|
| 01/26/2015 |
SC 13G/A
| Invesco Ltd. reports a 2.6% stake in Auxilium Pharmaceuticals Inc. |
| 01/20/2015 |
8-K
| Other Events |
| 01/20/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 01/16/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
|
|
|